56 related articles for article (PubMed ID: 21901365)
1. Experimental computed tomography-guided vena cava puncture in pigs for percutaneous brachytherapy of middle mediastinal lymph node metastases.
Zhao M; Liu B; Li SY; Wang YZ; Li YL; Hertzanu Y
Chin Med J (Engl); 2015 Apr; 128(8):1079-83. PubMed ID: 25881603
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced CT and PET-CT characteristics of primary tracheal lymphoepithelioma-like carcinoma: case series.
Liu Q; Zeng F; Peng C; Lin Y; Wang Q; Zeng Q
Transl Lung Cancer Res; 2024 May; 13(5):1101-1109. PubMed ID: 38854950
[TBL] [Abstract][Full Text] [Related]
3. An Unusual Case of Myocardial Localization of Non-Small Cell Lung Cancer Metastasis: A Case Report and Review of Literature.
Tagliabue L; Manfrinato G; Luciani A
Indian J Nucl Med; 2017; 32(3):208-210. PubMed ID: 28680205
[TBL] [Abstract][Full Text] [Related]
4. Transient
Karimi-Galougahi M; Yousefi-Koma A; Khalili N; Bakhshayeshkaram M; Haseli S
IDCases; 2020; 22():e00981. PubMed ID: 33173754
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary mediastinal actinomycosis with "pound cake sign" on magnetic resonance imaging mimicking an infiltrative malignant tumor: A case report.
Yan N; Sugihara F; Hayashi N; Sasaki T; Ishii Y; Hayashi H; Kumita SI
Radiol Case Rep; 2024 Aug; 19(8):3334-3338. PubMed ID: 38860267
[TBL] [Abstract][Full Text] [Related]
6. Take CT, get PET free: AI-powered breakthrough in lung cancer diagnosis and prognosis.
Wang T; Yang X
Cell Rep Med; 2024 Apr; 5(4):101486. PubMed ID: 38631288
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of [
Zhang L; E H; Huang J; Wu J; Li Q; Hou L; Li C; Dai C; Deng J; Yang M; Ma M; Ren Y; Luo Q; Zhao D; Chen C
Eur Radiol; 2023 Dec; 33(12):8564-8572. PubMed ID: 37464112
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of the model consisting of DDX49, EGFR, and T-stage as a possible risk factor for lymph node metastasis in patients with lung cancer.
Zhang Z; Lian X; Yue H; Xiang D; Niu Z
Thorac Cancer; 2023 Jun; 14(16):1492-1499. PubMed ID: 37096455
[TBL] [Abstract][Full Text] [Related]
9. Is SUVmax Helpful in the Differential Diagnosis of Enlarged Mediastinal Lymph Nodes? A Pilot Study.
Yu C; Xia X; Qin C; Sun X; Zhang Y; Lan X
Contrast Media Mol Imaging; 2018; 2018():3417190. PubMed ID: 30510493
[TBL] [Abstract][Full Text] [Related]
10. Clinically simplified screening methods to evaluate maximum standard uptake value from F-18-FDG-PET/CT in patients with non-small-cell lung cancer.
Takeda Y; Miura K; Sato T; Tsujimoto Y; Nagano N; Nagasaka S; Kina S; Sugiyama H
Medicine (Baltimore); 2018 Jun; 97(26):e11226. PubMed ID: 29952981
[TBL] [Abstract][Full Text] [Related]
11. Lymph node ratio as a prognostic factor in patients with pathological N2 non-small cell lung cancer.
Tamura M; Matsumoto I; Saito D; Yoshida S; Takata M; Takemura H
World J Surg Oncol; 2016 Nov; 14(1):295. PubMed ID: 27884195
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound techniques in the evaluation of the mediastinum, part I: endoscopic ultrasound (EUS), endobronchial ultrasound (EBUS) and transcutaneous mediastinal ultrasound (TMUS), introduction into ultrasound techniques.
Dietrich CF; Annema JT; Clementsen P; Cui XW; Borst MM; Jenssen C
J Thorac Dis; 2015 Sep; 7(9):E311-25. PubMed ID: 26543620
[TBL] [Abstract][Full Text] [Related]
13. Implications of false negative and false positive diagnosis in lymph node staging of NSCLC by means of ¹⁸F-FDG PET/CT.
Li S; Zheng Q; Ma Y; Wang Y; Feng Y; Zhao B; Yang Y
PLoS One; 2013; 8(10):e78552. PubMed ID: 24205256
[TBL] [Abstract][Full Text] [Related]
14. Role of FDG-PET scans in staging, response assessment, and follow-up care for non-small cell lung cancer.
Cuaron J; Dunphy M; Rimner A
Front Oncol; 2012; 2():208. PubMed ID: 23316478
[TBL] [Abstract][Full Text] [Related]
15. Additional value of FDG-PET to contrast enhanced-computed tomography (CT) for the diagnosis of mediastinal lymph node metastasis in non-small cell lung cancer: a Japanese multicenter clinical study.
Kubota K; Murakami K; Inoue T; Itoh H; Saga T; Shiomi S; Hatazawa J
Ann Nucl Med; 2011 Dec; 25(10):777-86. PubMed ID: 21901365
[TBL] [Abstract][Full Text] [Related]
16. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of 18F-FDG PET/CT for lymph node staging in non-small-cell lung cancers.
Liu BJ; Dong JC; Xu CQ; Zuo CT; Le JJ; Guan YH; Zhao J; Wu JF; Duan XH; Cao YX
Chin Med J (Engl); 2009 Aug; 122(15):1749-54. PubMed ID: 19781319
[TBL] [Abstract][Full Text] [Related]
18. FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.
Ohtsuka T; Nomori H; Ebihara A; Watanabe K; Kaji M; Naruke T; Suemasu K; Uno K
Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):89-94. PubMed ID: 16702929
[TBL] [Abstract][Full Text] [Related]
19. Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer.
Yang W; Fu Z; Yu J; Yuan S; Zhang B; Li D; Xing L; Zhao D; Mu D; Sun X; Fang Y; Huang Y; Li W
Lung Cancer; 2008 Jul; 61(1):35-43. PubMed ID: 18177978
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]